Consensus Icade

Equities

ICAD

FR0000035081

Market Closed - Euronext Paris 11:37:13 2024-04-18 am EDT 5-day change 1st Jan Change
24.16 EUR +1.09% Intraday chart for Icade -0.74% -32.02%

Evolution of the average Target Price on Icade

Price target over the last 5 years

History of analyst recommendation changes

ba8330b6d44ca2690ea1193f2.OBx5Is-aVK7H7CsojjflV-HK12sKh_D_yl1vx8AEVjQ.SXgOWIatLsLxixJ-_XCoH6XzlR5s5ZWe-TQf8ZJ-BwV6Txxkqd4t1pCGYg~0fd2c1edcd425d1cbff96b2952b3f0e5
Destabilised French Residential market. Alphavalue
Invest Securities Cuts Icade PT, Maintains Buy Rating MT
ICADE : Invest Securities lowers its target price CF
ICADE : No return to a negative opinion. At least for now. Alphavalue
ICADE : Defensive strategic roadmap Alphavalue
Invest Securities Lowers Icade's PT, Maintains Buy Rating MT
Bank of Japan Drops Hard Rate Cap; Worker Pay Poses Problem for Fed; Has 10-Year Treasury Yield Peaked? DJ
Higher Bond Yields Could End Rate Rises; Fed Debates Whether Old Growth-Inflation Model Still Applies DJ
ICADE : Sharp fall in Residential development's net reservations Alphavalue
ICADE : Awaiting a new strategic roadmap Alphavalue
FTSE 100 Closes Up 0.1% as Investors Eye Fed, ECB Rate Decisions DJ
UK Wage Growth Will Keep Interest Rates High DJ
ICADE : Prepare for Healthcare's full deconsolidation Alphavalue
ICADE : Halving of Residential reservations in Q1 23 Alphavalue
Icade : PR Icade - Standard & Poor's affirms Icade's BBB+ rating with a stable outlook PU
ICADE : Disposing of the Cullinan Alphavalue
ICADE : Residential development: much more resilient than expected Alphavalue
ICADE : Slowing French residential development Alphavalue
ICADE : Another quarter of rising vacancy in Offices Alphavalue
Please watch your step Alphavalue
ICADE : Looking at the impact of future rising construction costs Alphavalue
ICADE : Healthcare due to offset Offices for a while Alphavalue
ICADE : Rising vacancy in French offices in Q3 21 indicates worse to come in our view Alphavalue
ICADE : MAINTAINS ITS LEADING POSITION ATOP 2021 RANKINGS FROM ESG RATING AGENCIES PU
ICADE : Stable values in offices, working on Icade Santé's IPO in H2 21 Alphavalue
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
24.16 EUR
Average target price
32.09 EUR
Spread / Average Target
+32.82%
High Price Target
53 EUR
Spread / Highest target
+119.37%
Low Price Target
22.8 EUR
Spread / Lowest Target
-5.63%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Icade

Invest Securities
alphavalue Christian Auzanneau
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Quarterly revenue - Rate of surprise